| 000 | 01506 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513062359.0 | ||
| 264 | 0 | _c19940420 | |
| 008 | 199404s 0 0 eng d | ||
| 022 | _a0028-1298 | ||
| 024 | 7 |
_a10.1007/BF00167242 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDhein, S | |
| 245 | 0 | 0 |
_aPropranolol unmasks class III like electrophysiological properties of norepinephrine. _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cDec 1993 |
||
| 300 |
_a643-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 | _aAdrenergic alpha-1 Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aElectrodes |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aPrazosin _xpharmacology |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aVentricular Pressure _xdrug effects |
| 700 | 1 | _aGerwin, R | |
| 700 | 1 | _aZiskoven, U | |
| 700 | 1 | _aSchott, M | |
| 700 | 1 | _aRump, A F | |
| 700 | 1 | _aZhao, Y | |
| 700 | 1 | _aSalameh, A | |
| 700 | 1 | _aKlaus, W | |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 348 _gno. 6 _gp. 643-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00167242 _zAvailable from publisher's website |
| 999 |
_c8133230 _d8133230 |
||